Atrial Fibrillation
Conditions
Brief summary
Prospective data collection of patients undergoing Atrial Fibrillation Ablation.
Detailed description
Clinicians who have experience using low dose fluoroscopy including use of Carto Mapping system will consent patients to allow data collection and a 12 month f/up visit to track adverse events. Clinicians will follow a protocol which will be similar to their standard of care for ablations.
Interventions
PROCEDUREAblation
Sponsors
Beacon Medical Group
Brigham and Women's Hospital
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Stanford University
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patient meets accepted AHA/ACC/HRS guideline indications for catheter ablation of paroxysmal or persistent AF * First or subsequent ablation procedures may be included * Age 18-75
Exclusion criteria
* Known venous malformations or implanted instrumentation (IVC filter) * Known PV stenosis * Unable to provide consent * H/O mechanical mitral valve replacement (unable to rely on EA mapping only) * Documented left atrial thrombus * Prior ASD repair Pregnancy * NYHA \>=3 * EF less than 35% * CHF within 90 daysRecent MI or coronary revascularization within 90 days * NOTE: H/O implanted pacemaker or ICD with transvenous leads will NOT be an
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Atrial Fibrillation | 12 months | Determine Atrial Fibrillation burden at 12 month visit by reviewing monitoring systems that capture this data |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fluoroscopic Usage | post operative | To determine total amount of radiation used at each procedure by estimation of mGy |
Countries
United States
Outcome results
None listed